Advertisement
U.S. markets close in 3 hours 30 minutes

Aclaris Therapeutics, Inc. (ACRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.2250+0.0350 (+2.95%)
As of 12:30PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close1.1900
Open1.1900
Bid1.2200 x 3100
Ask1.2300 x 3200
Day's Range1.2000 - 1.2500
52 Week Range0.5900 - 12.9300
Volume421,479
Avg. Volume2,454,360
Market Cap86.774M
Beta (5Y Monthly)0.22
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ACRS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Aclaris Therapeutics, Inc.
    Daily – Vickers Top Buyers & Sellers for 08/29/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    6 months agoArgus Research
View more